A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
Not yet recruitingOBSERVATIONAL
Enrollment
3,000
Participants
Timeline
Start Date
July 31, 2022
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Conditions
Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
Trial Locations (1)
Unknown
Yonsei University Health System, Severance Hospital, Seoul
All Listed Sponsors
lead
Yonsei University
OTHER
NCT05401708 - A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes | Biotech Hunter | Biotech Hunter